A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : beta2GPI / anti-beta2-glycoprotein I

[Related PubMed/MEDLINE]
Total Number of Papers: 68
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   beta2GPI  (>> Co-occurring Abbreviation)
Long Form:   anti-beta2-glycoprotein I
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Atrial thrombus as a complication of SLE and APS in an 8-year-old child. LN, SLE
2020 EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies. LMWH, PM
2020 Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases. aCL, aPL, LAC, oARD, PAPS
2020 High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients. aPL, SLE
2020 Prevalence of antiphospholipid antibodies in Behcet's disease: A systematic review and meta-analysis. aCL, aPLs, BD, CIs, LA, NOS, ORs
2019 Autoantibody detection is not recommended for chronic pancreatitis: a cross-sectional Study of 557 patients. AIP, CP
2019 Detection of anti-domain I antibodies by chemiluminescence enables the identification of high-risk antiphospholipid syndrome patients: A multicenter multiplatform study. aPLs, APS, CL, DI, ORs
2019 Methodology of generation and purification of anti-beta 2 glycoprotein I antibodies. APS
2018 Possible relationship between antiphospholipid antibodies and embolic events in infective endocarditis. aCL, aPL, EE, IE
10  2018 Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-beta2-GPI antibodies. APS, IRAK, NF-kappaB, TF
11  2017 Comorbid association of antiphospholipid antibodies and migraine: A systematic review and meta-analysis. aCL, aPLs, CI, LA, NOS, OR
12  2017 Diagnosis and management of the antiphospholipid syndrome. aCL, APLA, APS, DOAC
13  2017 Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome. aCL, aPL, APS, LA, VKA
14  2017 The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study. aGAPSS, APS, PAPS, VKA
15  2016 Simultaneous Quantification of Anticardiolipin IgG and IgM by Time Resolved Fluoroimmunoassay. aCL, APS, CV, LA, TR-FIA
16  2016 The role of anti-phospholipid antibodies in autoimmune reproductive failure. aPL
17  2015 Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature. aCL, aPL, APS, IVIG, LA, LDA, LMWH
18  2015 TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome. aPL, APS, IgG-APS, TLR4
19  2014 Annexin A2 autoantibodies in thrombosis and autoimmune diseases. Ab, ANXA2, APS, PL
20  2014 Epigallocatechin-3-gallate inhibits TF and TNF-alpha expression induced by the anti-beta2GPI/beta2GPI complex in human THP-1 cells. APS, EGCG, JNK, MAPKs, NF-kappaB, TF, TLR4, TNF-alpha
21  2014 Frequency of autoantibodies and connective tissue diseases in Chinese patients with optic neuritis. a-dsDNA, ACA, ANA, AQP4-Ab, BON, CTDs, ION, ON, RF, RON, SD-OCT, SS
22  2014 Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies. aCL, APLA, APLS, LAC
23  2013 Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases. aCL, AID, aPL, LA, THE
24  2013 Synergistic thrombotic risk of antibodies against phosphatidylserine and prothrombin and beta-2-glycoprotein I. PS/PT
25  2013 Variability in exposure of epitope G40-R43 of domain i in commercial anti-beta2-glycoprotein I IgG ELISAs. APS, G40-R43
26  2011 Autoantibodies in lupus: culprits or passive bystanders? CVD, NMDAR, NP
27  2010 An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies. APS, CI, LAC, OR
28  2010 Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases. GMT, LN
29  2010 Correlation between beta-2-glycoprotein I gene polymorphism and anti-beta-2 glycoprotein I antibodies in patients with multibacillary leprosy. MB, SNPs, TEP
30  2009 Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. aCL, aPL, APS, LA
31  2009 The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. APS
32  2008 Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis: Report of a family with multiple anti-phospholipid positive members. aPL, TLRs
33  2007 Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies. aPL, APS, RU, SLE, SPR
34  2006 Antibodies to beta2-glycoprotein I and annexin V in women with early and late idiopathic recurrent spontaneous abortions. ACA, APA, LAC, RSA
35  2006 Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. AnxA5, aPL, LAC
36  2006 The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production. aCL, aPL, VP1u
37  2006 Valine/Leucine247 polymorphism of beta2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-beta2-glycoprotein I antibodies. APS, SNP
38  2005 Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome? anti-oxLDL antibodies
39  2005 Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. DVT, LAC, OR
40  2005 Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. ---
41  2004 Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. APS
42  2004 Mechanisms of autoantibody-induced monocyte tissue factor expression. APS, TF, TFPI
43  2004 Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model. aCL, AECA, aPLs, APS, TEM
44  2004 Study of anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with ischemic stroke. ---
45  2003 Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome. aCL, anti-beta2GPI, RA
46  2003 Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'. LAC
47  2003 Is the determination of anti-beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome? ACA, LA, VTE
48  2003 Relation of preexisting anti-beta2GPI antibodies to infarct size in a rat model. aPL, LAD
49  2002 Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. ACA, APS
50  2002 The inhibition of protein C anticoagulant activity by anti-beta2-glycoprotein I (beta2GPI) antibodies isolated from patients with antiphospholipid syndrome by chromatography methods. APC, aPL, APS
51  2002 [Annexin V levels in survivors of early myocardial infarction]. aPL
52  2001 Beta2-glycoprotein I and atherosclerosis. ---
53  2000 Effect of anti-beta2glycoprotein I Lupus Anticoagulants on fibrin polymerization and fibrinolysis. dRVVT, LA, PL
54  2000 Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL). aCL, ANCA, IIF, MPO, PCR, PR3
55  2000 Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies. IM, PAPS, SLE
56  1999 Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. aCL, aPL, APS, ELISA, PAPS, SLE, SLE/APS
57  1999 dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies. dRVVT, KCT, LA, PLs, TTI
58  1999 Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype. APS, LA, SLE
59  1998 Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. aCL
60  1998 Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-beta2-glycoprotein I antibodies. AMA M5, anti-CL, LA, PAPS, SLE
61  1998 Dendritic cells preferentially internalize apoptotic cells opsonized by anti-beta2-glycoprotein I antibodies. aPL, DC
62  1998 Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C. APCR, aPL, dRVVT, FVa, KCT, SD
63  1998 The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity--discrimination between functional and non-functional anti-prothrombin-antibodies. LAC
64  1997 Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids. aCLs, LA
65  1996 Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation. ACA
66  1995 Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. LA
67  1994 Antiphospholipid and anti-beta 2 glycoprotein I antibodies in monozygotic twin sisters. ---
68  1991 [Anti-beta 2 glycoprotein I antibodies in systemic lupus erythematosus: a marker of thrombosis associated with a circulating anticoagulant]. ---